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Serotonin Inhibition of Synaptic Transmission:
Gao Decreases the Abundance of UNC-13
at Release Sites
including locomotion (Horvitz et al., 1982; SeÂ galat et al.,
1995), egg laying (Trent et al., 1983; Waggoner et al.,
1998), and feeding (Avery and Horvitz, 1990). Six genes
are required for serotonin stimulation of the egg laying
muscles (Trent et al., 1983). Mutations in unc-2, which
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prevent adaptation of animals to serotonin-induced inhi-Moleculare et Cellulaire
bition of locomotion (Schafer and Kenyon, 1995). Muta-CNRS
tions that reduce the activity of goa-1 Gao confer partial660 Route des Lucioles
resistance to serotonin-induced inhibition of locomotionSophia Antipolis
(Mendel et al., 1995; SeÂ galat et al., 1995). Taken together,06560 Valbonne
these studies define a set of genes that play some roleFrance
in serotonin signal transduction. However, it remains
unclear what cells are regulated by serotonin and how
serotonin regulates the activity of these cells.Summary
Serotonin often acts as a neuromodulator regulating
transmission by other neurotransmitters. In some cases,We show that serotonin inhibits synaptic transmission
serotonin has been shown to enhance synaptic trans-at C. elegans neuromuscular junctions, and we de-
mission (Byrne and Kandel, 1996; Wang and Zucker,scribe a signaling pathway that mediates this effect.
1998), whereas, in other cases, serotonin inhibits synap-Release of acetylcholine from motor neurons was as-
tic transmission (Singer et al., 1996; McDearmid et al.,sayed by measuring the sensitivity of intact animals
1997). We show here that serotonin inhibits synapticto the acetylcholinesterase inhibitor aldicarb. By this
transmission at C. elegans neuromuscular junctions andassay, exogenous serotonin inhibited acetylcholine re-
that this effect is mediated (at least in part) by reducinglease, whereas serotonin antagonists stimulated re-
the abundance of presynaptic DAG-binding proteinlease. The effects of serotonin on synaptic transmis-
UNC-13 at release sites.sion were mediated by GOA-1 (a Gao subunit) and
DGK-1 (a diacylglycerol [DAG] kinase), both of which
Resultsact in the ventral cord motor neurons. Mutants lacking
goa-1 Gao accumulated abnormally high levels of the
cat-1 and dgk-1 Mutants Have DefectsDAG-binding protein UNC-13 at motor neuron nerve
in Serotonin Signalingterminals, suggesting that serotonin inhibits synaptic
Exogenous serotonin reduces the rate of locomotiontransmission by decreasing the abundance of UNC-
(Horvitz et al., 1982; SeÂ galat et al., 1995), whereas it13 at release sites.
stimulates the rate of egg laying (Trent et al., 1983; Wein-
shenker et al., 1995). The effects of serotonin on theseIntroduction
two behaviors are likely mediated by distinct pathways,
as particular mutations differentially alter these two as-Monoamines are thought to play a pivotal role in modu-
pects of serotonin function. For example, goa-1 Gao islating the activity of neural circuits, often controlling
required for serotonin-mediated inhibition of locomotionglobal behavioral states of an animal. For example, sero-
but not for serotonin-mediated stimulation of egg laying
tonin has been implicated in several aspects of mood
(Mendel et al., 1995; SeÂ galat et al., 1995). To identify
and behavior, including depression (Maes and Meltzer,
new components of the serotonin signaling pathway,
1994), eating disorders (Tecott et al., 1995), alcohol con- we isolated mutations that block serotonin inhibition of
sumption (Crabbe et al., 1996), and aggression (Berman locomotion. We describe here two genes identified in
et al., 1997; Saudou et al., 1994). This physiological func- this screen, cat-1 and dgk-1.
tion has been conserved across phylogeny, as serotonin The cat-1 gene encodes a vesicular monoamine trans-
controls the behavioral states of animals ranging from porter (VMAT), which pumps serotonin and dopamine
lobsters (Edwards and Kravitz, 1997) to the nematode C. into synaptic vesicles (Duerr et al., 1999). We isolated
elegans (Sawin, 1996; Waggoner et al., 1998) to humans cat-1(nu90) as a mutation that causes hyperactive loco-
(Soubrie, 1988; Maes and Meltzer, 1994; Berman et al., motion (Figure 1A) and reduced egg laying rates (S. N.
1997). and J. M. K., unpublished data; Duerr et al., 1999), both
C. elegans has been used as a genetic model to study consistent with an underlying defect in serotonin signal-
serotonin signaling in vivo. C. elegans has only five ing. The cat-1(e1111) allele (Sulston et al., 1975; Desai
classes of serotonergic neurons (Desai et al., 1988), one et al., 1988) corresponds to a nonsense mutation (Duerr
of which (NSM) is a neurosecretory cell that produces et al., 1999) and causes similar behavioral defects to
serotonin as a neurohormone (Albertson and Thomson, those observed in cat-1(nu90) mutants (Duerr et al.,
1976). Several behaviors are modulated by serotonin, 1999).
The dgk-1 gene was defined by five recessive alleles.
Homozygous dgk-1 mutants had hyperactive locomo-³ To whom correspondence should be addressed (e-mail: joshkap@
socrates.berkeley.edu). tion (Figure 1A) and laid eggs constitutively (data not
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Figure 1. Serotonin and GOA-1 Signaling in
cat-1 and dgk-1 Mutants
Behavioral assays and drug treatments and
transgenic animals were as described in the
Experimental Procedures. Drug treatments
are indicated by the legends.
(A) Locomotion of cat-1(e1111) was partially
resistant to fluoxetine but not to serotonin,
whereas locomotion of dgk-1(nu199) was
partially resistant to both. Animals (nuIs45)
expressing gfp::dgk-1 (gfp-d) or a heat
shock±promoted dgk1a cDNA (hsdgk) had
slower locomotion rates than wild type.
(B) Egg laying of cat-1(e1111) mutants was
partially resistant to fluoxetine but was sensi-
tive to serotonin, whereas that of dgk-
1(nu199) mutants was fully sensitive to both.
(C) Effects of GOA-1 activity on locomotion.
GOA-1 signaling was increased by express-
ing transgenes containing wild-type GOA-1
or GOA-1(Q205L). In cat-1(e1111) mutants,
GOA-1 inhibited locomotion while the effect
of GOA-1 activity on locomotion was signifi-
cantly reduced in dgk-1(nu199) mutants. Er-
rors indicate the standard error of the mean.
Asterisk indicates animals expressing GOA-
1(Q205L) whose standard errors were less
than 0.12.
shown). In addition to these phenotypes, homozygous resistant to fluoxetine but remained sensitive to exoge-
nous serotonin (Figures 1A and 1B). Therefore, cat-1dgk-1 mutants also tend to form large clumps of animals
at the edges of the bacterial lawn (data not shown), mutants fit the pharmacological profile predicted for
a defect in the serotonergic neurons. Similarly, cat-4which has been termed the bordering phenotype (de
Bono and Bargmann, 1998). The bordering phenotype mutants, which have abnormally low levels of endoge-
nous serotonin (Desai et al., 1988), also fit the profile foroccurs in mutants lacking a putative neuropeptide re-
ceptor (NPR-1) (de Bono and Bargmann, 1998) but is a defect in the serotonergic neurons (Figure 1B).
By contrast, the hyperactive locomotion of dgk-1 mu-not seen in other serotonin-defective mutants (e.g., cat-1
and cat-4), suggesting that the dgk-1 gene acts both in tants was partially resistant to both serotonin and fluox-
etine (Figure 1A). These results suggested that dgk-1serotonin and in peptidergic signaling pathways.
acts in the serotonin target tissues. Interestingly, not all
serotonin targets required dgk-1, since the egg layingdgk-1 Mutations Cause Defects in Serotonin
Target Cells of dgk-1 mutants was still stimulated by serotonin (Fig-
ure 1B). Thus, dgk-1 is required for serotonin inhibitionThe behavioral deficits observed in dgk-1 mutants could
reflect impaired function of either the serotonergic neu- of locomotion but not for serotonin stimulation of egg
laying.rons or the serotonin target cells. In principle, one can
distinguish between these possibilities by testing the
response of mutant animals to exogenous serotonin or
to fluoxetine, which exaggerates the effects of endoge- dgk-1 Encodes a Diacylglycerol Kinase
We mapped the dgk-1 gene to a small region on the leftnous serotonin by inhibiting plasma membrane seroto-
nin reuptake pumps. A normal response to fluoxetine arm of the X chromosome between aex-3 and unc-1. A
cosmid clone (C06G11) from this region corrected therequires function of both the serotonergic neurons and
the serotonin-responding cells, whereas a normal re- locomotion and egg laying defects of dgk-1 mutants in
transgenic animals (data not shown). All five dgk-1 al-sponse to serotonin only requires the latter (Trent et al.,
1983; Weinshenker et al., 1995); therefore, respon- leles corresponded to mutations in a gene (C09E10.2,
accession U49946), which encodes a protein that is 38%siveness to these drugs allowed us to distinguish mu-
tants with defects in these two cell types. identical to a human diacylglycerol (DAG) kinase, DGKu
(Houssa et al., 1997) (Figures 2A and 2B). Four dgk-1To confirm the validity of this approach, we tested
whether responsiveness to these drugs correctly pre- alleles caused very similar behavioral defects and
potentially correspond to severe loss-of-function muta-dicts the site of cat-1 function. The cat-1 VMAT is ex-
pressed in serotonergic and dopaminergic neurons, tions. The alleles nu62 and n892 are nonsense muta-
tions, while nu199 and n2949 disrupt donor and ac-where it mediates transport of these monoamines into
synaptic vesicles (Duerr et al., 1999). The locomotion ceptor splicing consensus signals in intron 7, all of
which should reduce DGK-1 activity. A fifth allele (nu76)and egg laying behaviors of cat-1 mutants were partially
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Figure 2. Cloning of dgk-1
(A) Genome structure of the dgk-1 gene. Putative domains based on homology to DGKu, dgk-1b splice form, and sequence changes in dgk-1
alleles are indicated. The site of the GFP fusion is shown.
(B) Translated dgk-1a cDNA (KP#137) aligned with human DGKu protein. Identities (38%) are indicated by vertical lines, similarities by dots.
(C) DGK-1 expressed in HEK 293 cells has DAG kinase activity using two different diglyceride substrates. Phosphatidic acid was isolated by
thin layer chromatography and incorporation of 32P into the phosphatidic acid band is a quantitative measure of the activity of diacylglycerol
kinase activity. The activity of human DGKz isoform is shown for comparison.
corresponds to a missense mutation (A247V) in a non- expression vector, restored normal locomotion rates,
demonstrating that DGK-1a is a functional form of dgk-1catalytic domain and causes less severe hyperactivity.
Expression of a full-length gfp::dgk-1 translational fu- DAG kinase and can act in adults (Figure 1A).
DAG kinases are encoded by a large gene family thatsion construct (Figure 2A) in dgk-1 mutants reduced the
locomotion rate below that of wild-type animals and has been conserved across phylogeny. The genome
database predicts at least five distinct C. elegans DAGrestored responsiveness to exogenous serotonin and
fluoxetine (Figure 1A). These results demonstrated kinase isoforms, and twelve mammalian isoforms have
been described (Topham and Prescott, 1999). All DAGthat the gene identified by these mutations encodes
a putative DAG kinase. Furthermore, since wild-type kinases share a common enzymatic activity, phosphory-
lation of DAG to produce phosphatidic acid. To confirmtransgenes rescued dgk-1 mutant phenotypes, these
results also suggest that dgk-1 alleles reduce gene ac- that dgk-1 encodes a catalytically active DAG kinase,
we expressed full-length DGK-1 cDNAs in HEK293 cellstivity.
We isolated full-length DGK-1 cDNA clones and deter- (Figure 2C). Cells transfected with the DGK-1 expression
construct produced significantly more DAG kinase ac-mined their sequence (Figure 2B). The predicted DGK-1
protein contains 950 amino acids, which share several tivity than nontransfected cells, and this kinase was ac-
tive with two different diglyceride substrates.salient features with human DGKu. Like DGKu, DGK-1
has three amino terminal cysteine-rich domains (which
are thought to bind DAG), a potential pleckstrin homol- cat-1 VMAT Acts Upstream of goa-1 Gao
Prior results suggested that goa-1 Gao mediates manyogy domain, and a catalytic domain. Although it is highly
expressed in the brain, the function of DGKu in neural of the effects of serotonin (Mendel et al., 1995; SeÂ galat
et al., 1995). The similarity of the behavioral defectssignaling has not been determined. Two alternatively
spliced forms (DGK-1a and DGK-1b) were detected, observed in cat-1 and dgk-1 mutants to those observed
in goa-1 mutants suggested that these genes are partwhich differ by three amino acids in a region of unknown
function (Figure 2A). Transient expression of the DGK-1a of a common signaling pathway. To further examine the
role of GOA-1 in serotonin signaling, we tested whethercDNA in adult dgk-1 mutants, utilizing a heat shock
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Table 1. Analysis of Behaviors
Effect of CAT-1 on GOA-1 Signaling
Body Bends/Minute 6 SEM
(Number of Animals)
Wild type 10.6 6 0.2 (115)
cat-1(e1111) 14.1 6 0.3 (70)
egl-10(md176) 2.8 6 0.2 (20)
egl-10(md176); cat-1(e1111) 4.1 6 0.4 (10)
DGK-1 Is Required for GOA-1 Regulation of Locomotion
Body Bends/Minute 6 SEM (Number of Animals)
Genotype No Transgene GFP::DGK-1
Wild type 10.6 6 0.2 (115) ND
dgk-1(nu199) 18.7 6 0.3 (80) 4.1 6 0.4 (15)
goa-1(n1134) 18.1 6 0.6 (10) 10.7 6 1.0 (10)
egl-10(md176) 2.8 6 0.2 (20) ND
egl-10(md176); dgk-1(nu199) 15.3 6 0.7 (10) ND
Locomotion rates were compared in various strains, as detailed in the Experimental Procedures. The mutation egl-10(md176) eliminates a
negative regulator of GOA-1, the RGS protein EGL-10 (Koelle and Horvitz, 1996). Values reported are means 6 standard errors.
exaggerated GOA-1 activity would compensate for re- 3A). Aldicarb enhances the effects of endogenously re-
leased acetylcholine by inhibiting acetylcholinesterase.duced release of endogenous serotonin (in cat-1 mu-
The ventral cord motor neurons, which drive locomotion,tants) or reduced serotonin signaling (in dgk-1 mutants).
utilize acetylcholine as their neurotransmitter (Rand andExaggerated GOA-1 activity was produced by three in-
Nonet, 1997). Consequently, aldicarb treatment causesdependent methodsÐeliminating an endogenous RGS
hypercontraction of the body wall muscles and paralysisprotein (EGL-10) that negatively regulates GOA-1 (Koelle
in wild-type animals but not in mutants (e.g., synaptotag-and Horvitz, 1996), overexpression of wild-type GOA-1
min mutants) that are unable to release acetylcholineor of a GTPase-defective mutant GOA-1(Q205L). In all
by exocytosis (Nonet et al., 1993; Nguyen et al., 1995;three cases, enhanced GOA-1 activity significantly re-
Miller et al., 1996). Wild-type animals treated with seroto-duced the locomotion rate of cat-1 mutants, suggesting
nin became resistant to aldicarb (Figure 3A; Table 2, linethat goa-1 Gao acts downstream of cat-1 VMAT (Figure 2). By contrast, cat-4 mutants, which have abnormally
1C and Table 1), as would be predicted if goa-1 Gao low levels of endogenous serotonin and dopamine (Suls-
mediates the effects of monoamine neurotransmitters ton et al., 1975; Desai et al., 1988), were hypersensitive
on locomotion. to aldicarb (Figure 3A). To confirm that the absence of
serotonin is sufficient to cause aldicarb sensitivity, we
also examined the effect of serotonin antagonists on
dgk-1 DAG Kinase Acts Downstream of or in Parallel aldicarb responsiveness. Wild-type animals treated with
with goa-1 Gao either of two serotonin antagonists, methiothepin (Fig-
In contrast to the cat-1 VMAT results, dgk-1 loss-of- ure 3A) or ketanserin (Table 2, line 4), also became hyper-
function mutations partially blocked the inhibition of lo- sensitive to aldicarb, whereas treatment with the dopa-
comotion caused by exaggerated goa-1 Gao signaling. mine antagonist haloperidol (Table 2, line 5) had no
effect. The effect of methiothepin on aldicarb sensitivityConversely, overexpression of GFP::DGK-1 reduced lo-
was mediated by a change in synaptic transmission atcomotion rates even in homozygous goa-1 Gao mutants
neuromuscular junctions, since unc-29 mutants, which(Figure 1C and Table 1). One simple model for DGK-1
lack a body muscle acetylcholine receptor (AChR), werefunction in locomotion would be that goa-1 Gao regu-
resistant to paralysis induced by treatment with methio-lates dgk-1 DAG kinase activity. Coexpression of GOA-
thepin and aldicarb (Figure 3A). These results suggest1(Q205L) did not alter the catalytic activity of DGK-1
that endogenous serotonin inhibits synaptic transmis-in transfected cells (data not shown); however, these
sion at neuromuscular junctions.results do not exclude the possibility that goa-1 Gao The effect of serotonin on synaptic transmission couldregulates dgk-1 DAG kinase by a less direct mechanism.
reflect inhibition of acetylcholine release by motor neu-
These results suggest that the dgk-1 DAG kinase acts rons or inhibition of the response of body muscles to
downstream of or in parallel with goa-1 Gao in serotonin acetylcholine. To distinguish between these possibili-
target tissues. ties, we tested the effect of serotonin treatment on the
response to the acetylcholine agonist levamisole (Figure
3B). We found that the paralysis induced by levamisole
The Serotonin Pathway Inhibits Acetylcholine in cat-4 mutants and in wild-type animals treated with
Release by Motor Neurons serotonin or serotonin antagonists was indistinguish-
To test if serotonin modulates neurotransmission in C. able from that seen in untreated wild-type controls (Fig-
elegans, we assayed synaptic release of acetylcholine ure 3B). By contrast, unc-29 AChR mutants were resis-
tant to both aldicarb and levamisole. These resultsby measuring sensitivity of animals to aldicarb (Figure
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resistant to aldicarb (lines 9 and 16). In all cases, re-
sponses of mutant and treated animals to the acetylcho-
line agonist levamisole were not significantly different
from controls (data not shown), suggesting that respon-
siveness of the body wall muscles to acetylcholine was
not altered. Taken together, these results suggest that
the serotonin/GOA-1/DGK-1 pathway regulates release
of acetylcholine by the ventral cord motor neurons.
goa-1 Gao and dgk-1 DAG Kinase Act in Ventral
Cord Motor Neurons
goa-1 Gao is expressed in most neurons, including the
ventral cord motor neurons that drive locomotion (Men-
del et al., 1995; SeÂ galat et al., 1995). Both a transcrip-
tional GFP reporter and a full-length gfp::dgk-1 transla-
tional fusion were also expressed in most neurons,
including the ventral cord motor neurons (Figures 4A
and 4B). In addition to the neurons, the GFP reporters
were also expressed in the excretory canals (Figure 4B).
The GFP::DGK-1 fusion protein was localized to an
organellar structure in the cell bodies of neurons and
appeared to be diffusely distributed throughout the cell
bodies and axons (Figure 4C). Thus, goa-1 Gao and
dgk-1 DAG kinase were both ubiquitously expressed in
the worm nervous system.
Given their expression patterns, we wondered if goa-1
Gao and dgk-1 DAG kinase act in the ventral cord motor
Figure 3. Serotonin Regulation of Neurotransmission neurons. We tested this hypothesis by specifically ex-
Synaptic release of endogenous acetylcholine (Ach) was measured pressing transgenes that alter the activity of these pro-
by determining the onset of paralysis induced by the acetylcho- teins in motor neurons, utilizing a motor neuron specific
linsterase inhibitor aldicarb.
expression vector. Expression of a constitutively active(A) The cat-4(e1141) mutation reduces endogenous levels of seroto-
form of goa-1 Gao (Q205L) in motor neurons inhibitednin and dopamine (Sulston et al., 1975; Desai et al., 1988) and caused
hypersensitivity to aldicarb. Similarly, the serotonin antagonist locomotion rate and made animals aldicarb resistant
methiothepin caused hypersensitivity to aldicarb. By contrast, treat- (Table 2, line 11). The goa-1 Gao subunit is predicted to
ment with exogenous serotonin (5-HT) reduced aldicarb sensitivity. by a substrate for ADP-ribosylation by pertussis toxin
Homozygous unc-29(e1072am) AChR mutants were resistant to pa- (Lochrie et al., 1991). Expression of the catalytic subunit
ralysis induced by treatment with methiothepin and aldicarb.
of pertussis toxin in motor neurons made animals hyper-(B) The sensitivity of body muscles to acetylcholine was measured
sensitive to aldicarb (Table 2, line 12) and producedby determining the onset of paralysis in response to the acetylcho-
line agonist levamisole. By this assay, untreated wild-type controls, hyperactive locomotion rates (data not shown). Simi-
serotonin-treated, methiothepin-treated, and untreated cat-4 mu- larly, expression of the GFP::DGK-1 fusion protein in
tants were equally sensitive to levamisole, whereas homozygous motor neurons restored normal aldicarb responsiveness
unc-29(e1072am) AChR mutants were resistant to levamisole. to homozygous dgk-1 mutants (Table 2, line 17). These
results suggest that goa-1 Gao and dgk-1 DAG kinase
act in motor neurons, directly or indirectly regulating
suggest that serotonin regulates synaptic transmission release of acetylcholine at neuromuscular junctions.
by inhibiting release of acetylcholine at neuromuscular Given their broad expression patterns, these genes
junctions. probably act in many other neural circuits as well.
goa-1 Gao Regulates the Abundance of UNC-13
The Effects of Serotonin on Acetylcholine Release at Nerve Terminals
Require goa-1 Gao and dgk-1 DAG Kinase The dgk-1 DAG kinase phosphorylates DAG, converting
Since goa-1 Gao and dgk-1 DAG kinase are required it into phosphatidic acid (Figure 2C). Therefore, eliminat-
for serotonin inhibition of locomotion (Figure 1A), we ing the dgk-1 DAG kinase is predicted to cause an in-
wondered whether these genes are also required for creased abundance of DAG, which could explain the
serotonin inhibition of acetylcholine release. Serotonin aldicarb hypersensitivity caused by dgk-1 mutations.
treatment did not cause aldicarb resistance in mutants Consistent with this idea, we showed that treating wild-
lacking either goa-1 Gao or dgk-1 DAG kinase (Table 2, type animals with phorbol esters induced hypersensitiv-
lines 7 and 14). In fact, homozygous goa-1 Gao (line 6) ity to aldicarb (Table 2, line 3), suggesting an increased
or dgk-1 DAG kinase (line 13) mutants were hypersensi- release of acetylcholine. Since dgk-1 mutations also
tive to aldicarb compared to wild-type controls (line 1), prevented goa-1 Gao induced paralysis, we wondered
consistent with an increased release of acetylcholine. whether phorbol ester treatment would block goa-1 Gao
Transient expression of either GOA-1(Q205L) or DGK-1a inhibition of acetylcholine release. Consistent with this
idea, we found that phorbol ester treatment produced(utilizing a heat shock expression vector) made animals
Neuron
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Table 2. Aldicarb Sensitivity of Serotonin Signaling Mutants
Serotonin Modulates ACh Release
Percent of Animals Paralyzed on
1 mM Aldicarb 6 SEM
Genotype [number of trials] Drug 40 min 80 min
1. wt [28] 4 6 1 81 6 3
2. wt [11] 5-HT 2 6 1 29 6 5
3. wt [10] PMA 99 6 1 100 6 0
4. wt [3] ketanserin 32 6 5 100 6 0
5. wt [3] haloperidol 7 6 1 97 6 1
GOA-1 Modulates ACh Release at the Motorneurons
Percent of Animals Paralyzed on
1 mM Aldicarb 6 SEM
Genotype [number of trials] Drug 40 min 80 min
6. goa-1(n1134) [3] 100 6 0 100 6 0
7. goa-1(n1134) [3] 5-HT 100 6 0 100 6 0
8. hs goa-1(Q205L) 2 hs [3] 12 6 5 100 6 0
9. hs goa-1(Q205L) 1 hs [5] 0 6 0 12 6 3
10. hs goa-1(Q205L) 1 hs [3] PMA 95 6 3 100 6 0
11. p.acr-2::goa-1(Q205L) [3] 8 6 3 39 6 2
12. p.acr-2::ptx [4] 39 6 4 100 6 0
DGK-1 Modulates ACh Release at the Motorneurons
Percent of Animals Paralyzed on
1 mM Aldicarb 6 SEM
Genotype [number of trials] Drug 40 min 80 min
13. dgk-1(nu199) [6] 77 6 9 100 6 0
14. dgk-1(nu199) [3] 5-HT 72 6 5 100 6 0
15. hs::dgk-1a 2 hs [3] 11 6 6 77 6 3
16. hs::dgk-1a 1 hs [3] 1 6 1 40 6 4
17. dgk-1(nu199); p.acr-2::gfp-dgk-1 [4] 19 6 3 88 6 4
The time course of aldicarb-induced paralysis was compared for the indicated strains and drug treatments, as detailed in the Experimental
Procedures. Two informative time points are shown for each condition. An early time point (40 min) is shown to illustrate hypersensitivity to
aldicarb. A late time point (80 min) is shown to illustrate resistance to aldicarb. Abbreviations are as follows: 5-HT, serotonin; PMA, phorbol
esters; acr-2, motor neuron specific expression vector; and hs, heat shock. Values reported are means 6 standard errors.
hypersensitivity to aldicarb even when the constitutive the C1 domain, both C2 domains, and the domain pre-
dicted to bind syntaxin (Betz et al., 1997), fused to GFP atform of goa-1 Gao (Q205L) was expressed (Table 2, line
10). One possible model to explain these results is that the carboxy terminus of UNC-13S. Expression of UNC-
13S::GFP in unc-13(e51) mutants restored normal loco-goa-1 Gao inhibits acetylcholine release by reducing the
levels of DAG at nerve terminals. However, these results motion rates and normal responsiveness to aldicarb,
suggesting that UNC-13S activity is sufficient to recon-do not exclude alternative models where DAG and goa-1
Gao antagonistically regulate acetycholine release even stitute synaptic transmission (data not shown). We com-
pared the distribution of UNC-13S::GFP in wild-type ani-though goa-1 Gao does not regulate the abundance of
DAG. mals and those with various defects in the serotonin
and GOA-1 signaling pathway (Figure 5). In wild-typeIf goa-1 Gao regulates the abundance of DAG in motor
neurons, then we might expect that goa-1 Gao would animals, UNC-13S::GFP was found in a diffuse staining
pattern in both the cell bodies and in the axons of theregulate the subcellular distribution of DAG-binding pro-
teins in motor neurons. Phorbol esters (which directly ventral nerve cord, with a few punctate structures in the
axons (Figure 5A; Table 3). The distribution of UNC-bind to C1 domains) have been shown to promote mem-
brane association of several DAG-binding proteins (Betz 13S::GFP was not significantly altered in mutants lack-
ing dgk-1 DAG kinase (Figure 5E; Table 3), nor in animalset al., 1998; Oancea et al., 1998). UNC-13 is a presynaptic
DAG-binding protein that stimulates neurotransmitter treated with phorbol esters (data not shown). We ob-
served a significant increase in the number of UNC-release (Maruyama and Brenner, 1991; Ahmed et al.,
1992; Kazanietz et al., 1995). These results suggested 13S::GFP punctate structures in the ventral nerve cords
of homozygous goa-1 mutants compared to wild-typethat a local change in DAG levels at neuromuscular junc-
tions could be visualized by observing a change in the controls (Figure 5C; Table 3). Mutants that lack endoge-
nous serotonin (e.g., cat-4) and wild-type animalsabundance of UNC-13 at nerve terminals.
To test this idea, we constructed an expression vector treated with the serotonin antagonist methiothepin had
a slight increase in the number of UNC-13S::GFP punctafor the short form of UNC-13 (UNC-13S, accession
3881735), which contains 1293 amino acids including (Figure 5B and Table 3). To test the importance of DAG
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under the control of the unc-13S promoter. In animals
coexpressing these two constructs, we see a clear colo-
calization of the UNC-13S::YFP punctate structures with
clusters of SNB-1::CFP (Figure 5F). In homozygous
goa-1 Gao mutants, 81% of the SNB-1::CFP puncta at
motor neuron nerve terminals colocalized with a corre-
sponding UNC-13S::YFP punctum (n 5 162 SNB-1::CFP
puncta and nine animals). These results confirm that
UNC-13S accumulates at acetylcholine release sites of
motor neurons in mutants lacking goa-1 Gao. Our data
are most consistent with the model that serotonin and
GOA-1 specifically regulate DAG levels at nerve termi-
nals and, as a consequence control, the abundance of
UNC-13 at acetylcholine release sites.
Discussion
We showed that serotonin modulates C. elegans loco-
motion by inhibiting release of acetylcholine at neuro-
muscular junctions. The effects of serotonin on acetyl-
choline release require goa-1 Gao and dgk-1 DAG
kinase, which act in the ventral cord motor neurons.
Finally, we showed that goa-1 Gao regulates the abun-
dance of the presynaptic protein UNC-13S at motor neu-
ron nerve terminals. Based on these results, we propose
a model for presynaptic inhibition by serotonin (Figure
6), which suggests that serotonin directly regulates
some aspect of synaptic vesicle exocytosis or recycling,
at least in this case.
The Role of goa-1 Gao in Aminergic Signaling
Prior work (Mendel et al., 1995; SeÂ galat et al., 1995)
showed that goa-1 mutants behave like animals that lackFigure 4. Expression of DGK-1
serotonin and are partially resistant to the behavioral(A) A transcriptional GFP reporter construct (nuIs15) is expressed
effects of exogenous serotonin. While these results sug-in many or all neurons, including cells in the in the head and tail
ganglia, (B) the ventral cord motor neurons (arrows), axons in the gest that GOA-1 is required in some manner for seroto-
ventral and dorsal nerve cords (VNC and DNC), and in the excretory nin signaling, they do not allow one to distinguish
canals (arrowheads). The full-length gfp::dgk-1 translational fusion whether GOA-1 is directly involved in serotonin signal
(nuIs45) has a similar expression pattern (data not shown). (C) Sub-
transduction or is a component of an interacting path-cellular localization of the DGK-1 protein was examined with the
way. Our current results provide further support for thefull-length gfp::dgk-1 translational fusion in nuIs45 animals. This
idea that GOA-1 plays a direct role in serotonin signaling,fusion construct rescues the dgk-1 mutant phenotype. In general,
GFP::DGK-1 is uniformly distributed throughout the cell body and perhaps by coupling directly to serotonin receptors.
axons of expresssing cells. In cell bodies, GFP::DGK-1 is localized First, goa-1 Gao acts downstream or parallel to serotonin
in a large perinuclear structure (arrows). release (as evidenced by epistasis experiments with
cat-1 VMAT mutations). Second, GOA-1 is required for
serotonin-mediated inhibition of synaptic transmission.binding for UNC-13S localization, we expressed a mu-
tant form of UNC-13S, H173K, in which we altered a Third, both serotonin and GOA-1 regulate the localiza-
tion of UNC-13 at motor neuron nerve terminals, sug-conserved histidine residue in the C1 domain that is
required for binding to phorbol esters (Betz et al., 1998). gesting that both act directly at the ventral cord neuro-
muscular junctions.Unlike the wild-type protein, UNC-13S(H173K)::GFP re-
mained diffusely distributed in goa-1 Gao mutants (Fig- On the other hand, it is likely that GOA-1 also plays
an important role in other neurotransmitter pathways.ure 5D and Table 3). Thus, goa-1 Gao regulates the distri-
bution of UNC-13S::GFP in the ventral nerve cord, and The effects of GOA-1 on egg laying cannot be explained
by a defect in serotonin signaling. Serotonin is an excit-this effect depends upon the ability of UNC-13S to bind
to DAG. atory neurotransmitter acting at the egg laying neuro-
muscular junctions, yet goa-1 Gao inhibits egg layingTo determine if the punctate structures containing
UNC-13S::GFP corresponded to acetylcholine release (Mendel et al., 1995; SeÂ galat et al., 1995). In addition,
the behavioral defects observed in goa-1 mutants aresites at neuromuscular junctions, we conducted double
labeling experiments. Neuromuscular junctions were la- much more severe than those seen in cat-1 mutants.
These results suggest that GOA-1 also mediates thebeled by expressing a cyan fluorescent protein tagged
synaptobrevin construct (SNB-1::CFP) in motor neurons effects of other unidentified neuromodulators. Consis-
tent with this idea, we found a substantially larger num-(Rongo et al., 1998). UNC-13S was visualized by ex-
pressing a yellow fluorescent protein tagged UNC-13S ber of UNC-13S::GFP containing puncta in the ventral
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Figure 5. Serotonin Regulates the Distribu-
tion of UNC-13S::GFP in the Ventral Nerve
Cord
(A±C) UNC-13S::GFP (expressed from the in-
ternal unc-13S promoter) was primarily dif-
fusely distributed in the ventral nerve cord
axons of untreated wild-type animals (A) but
became more punctate in the ventral cords
of animals treated with methiothepin (B), in
cat-4(e1141) mutants (data not shown), and
in homozygous goa-1(n1134) mutants (C).
(D) Unlike the wild-type protein, UNC-13S
(H173K)::GFP, which is predicted not to bind
to DAG (Betz et al., 1998), remains diffusely
distributed in homozygous goa-1(n1134) mu-
tants.
(E) UNC-13S::GFP remained primarily diffuse
in homozygous dgk-1 mutants.
(F) UNC-13S is localized to acetylcholine re-
lease sites in homozygous goa-1(n1134) Gao
mutants. Motor neuron nerve terminals and
UNC-13S were simultaneously visualized in
goa-1(n1134) mutants animals with CFP
tagged synaptobrevin (left), and YFP tagged
UNC-13S (middle). In the merged image
(right), it is clear that most SNB-1::CFP
puncta are colocalized with a UNC-13S::YFP
punctum. The SNB-1::CFP construct was
specifically expressed in motor neurons (with
the acr-2 promoter). The UNC-13S::YFP con-
struct was expressed throughout the nervous
system with the unc-13S promoter.
In (A)±(C) and (E), the integrated transgene
nuIs46 was used; in (D) and (F), transgenes
were carried as extrachromosomal arrays. In
(A)±(E), digital images were converted from
grayscale into a 32 color look-up table (NIH
Image) to visualize pixel intensities.
nerve cords of goa-1 mutants than in cat-4 mutants, with phorbol esters, dgk-1 mutations) restored acetyl-
choline release to animals expressing a constitutivewhich have reduced levels of serotonin and dopamine.
form of goa-1 Gao. Second, wild-type UNC-13S::GFP
accumulated at nerve terminals in goa-1 homozygotes,The Mechanism of goa-1 Gao Action
Our genetic results are most consistent with the model but UNC-13S(H173K)::GFP did not.
Our results are equally consistent with either of twothat goa-1 Gao decreases the abundance of DAG at
nerve terminals. This conclusion is based on two results. models for goa-1 Gao function. First, goa-1 Gao could
stimulate the activity of the dgk-1 DAG kinase, therebyFirst, manipulations that increase DAG levels (treatment
Table 3. Analysis of UNC-13::GFP Puncta
Genotype [Number of animals] Transgene GFP Puncta/10 mm 6 SEM
1. wild type [11] UNC-13S::GFP 1.0 6 0.2
2. wild type 1 methiothepin [10] UNC-13S::GFP 1.8 6 0.2
3. cat-4(e1141) [5] UNC-13S::GFP 1.5 6 0.1
4. goa-1(n1134) [11] UNC-13S::GFP 2.5 6 0.2
5. goa-1(n1134) [7] UNC-13S(H173K)::GFP 0.7 6 0.1
6. dgk-1(nu199) [10] UNC-13S::GFP 1.4 6 0.3
Localization of UNC-13S::GFP is controlled by serotonin and goa-1 Gao. Numbers of UNC-13S::GFP puncta in the ventral nerve cords were
compared for the indicated strains and drug treatments, as detailed in the Experimental Procedures. For comparison, the number of puncta
containing a mutant form of UNC-13 that is predicted not to bind DAG [UNC-13S(H173K)::GFP] is also shown. Digital images were thresholded
according to pixel intensity, and puncta were counted manually. Values reported are means 6 standard errors.
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rather than locally at neuromuscular junctions. For ex-
ample, since DGK-1::GFP appears to be uniformly dis-
tributed throughout the ventral cord, then it is likely that
DAG is elevated throughout the ventral cord in dgk-1
mutants. Although DAG is diffusely distributed in these
cases, its increased levels at release sites would none-
theless stimulate acetylcholine release. By contrast,
DAG could be selectively elevated at neuromuscular
junctions in goa-1 mutants, leading to the punctate dis-
tribution of UNC-13S::GFP. Alternatively, localization of
UNC-13S could require the coincidence of two distinct
signals. For example, since it contains both C1 and two
C2 domains, it is possible that UNC-13S localization is
dependent on both DAG and calcium. In this scenario,
dgk-1 DAG kinase mutants would only elevate DAG lev-
els and, hence, would not alter UNC-13S distribution. By
contrast, if goa-1 Gao regulates both DAG and calcium
levels, then changes in goa-1 Gao activity would alter
the distribution of UNC-13S.
Figure 6. A Model for Serotonin Inhibition of Synaptic Transmission
We propose that presynaptic DAG is a critical second messenger, Implications for the Mechanism
determining the amount of transmitter released by exocytosis. Exog- of Presynaptic Inhibition
enous phorbol esters cause hypersensitivity to aldicarb, implying Serotonin, goa-1 Gao, and dgk-1 DAG kinase all appearthat DAG at motor neuron nerve terminals facilitates acetylcholine
to inhibit synaptic transmission at neuromuscular junc-release. The inhibitory neuromodulator serotonin activates GOA-1,
tions. As both goa-1 Gao and dgk-1 DAG kinase act inthereby decreasing DAG levels at nerve terminals. Presynaptic DAG
motor neurons in this process, we propose that seroto-recruits UNC-13 to the neurotransmitter release sites, promoting
association with the nerve terminal membrane. Accumulation of nin acts directly on motor neuron nerve terminals, inhib-
UNC-13 at release sites could provide a mechanism for DAG-medi- iting synaptic transmission and thereby reducing loco-
ated stimulation of synaptic transmission. Other published experi- motion rates. Consistent with this idea, a GFP reporter
ments suggest that presynaptic DAG also stimulates release via
construct for a candidate C. elegans serotonin receptorprotein kinase C (Stevens and Sullivan, 1998). DGK-1 depletes
gene is expressed in a subset of the ventral cord motorDAG levels at nerve terminals by converting DAG into phosphatidic
neurons (T. Niacaris and L. Avery, personal communica-acid (PA).
tion), suggesting that serotonin does in fact act directly
on these cells. Serotonin is likely acting as a neurohor-
mone in this case, since none of the serotonergic neu-decreasing DAG levels at nerve terminals. We did not
rons are predicted to provide direct synaptic input todetect GOA-1 regulation of DGK-1 catalytic activity in
the motor neurons (White et al., 1986). Although thistransfected cells. Nonetheless, it remains possible that
is the simplest explanation of our results, it remainsGOA-1 regulates DGK-1 through a less direct mecha-
possible that serotonin acts more centrally (e.g., in sen-nism. For example, GOA-1 might regulate DGK-1 activity
sory or interneurons), even though goa-1 Gao and dgk-1through an intervening small GTP-binding protein (e.g.,
DAG kinase act in the motor neurons.Rac or Rho) (Tolias et al., 1998; Houssa et al., 1999).
How does serotonin inhibit neurotransmission? OurAlternatively, goa-1 Gao could regulate DAG levels by results suggest that DAG is an important second mes-
another mechanism with dgk-1 DAG kinase acting in
senger in this process (Figure 6). One potential target
parallel to regulate DAG levels. For example, goa-1 Gao of DAG in synaptic transmission is the DAG-binding
might inhibit egl-30 Gaq, a GTP-binding protein that protein UNC-13, which is required for exocytosis of syn-
stimulates phospholipase C activity (Brundage et al., aptic vesicles (Maruyama and Brenner, 1991; Ahmed et
1996). Both of these possibilities are consistent with al., 1992; Kazanietz et al., 1995). Recently published
our genetic analysis. Since these pathways are both results showed that overexpression of munc13±1, a
biosynthetic (producing DAG) and regulatory, mutations mammalian ortholog of UNC-13, confers enhanced
in the biosynthetic pathway (egl-30 Gaq) are predicted DAG-stimulated transmission at frog neuromuscular
to be epistatic to those in the goa-1 Gao pathway in junctions (Betz et al., 1998). Our results also support the
either of these scenarios, which we have observed (M. model that facilitation of synaptic transmission by DAG
Lackner and J. M. K., unpublished data). Therefore, is mediated (in part) by UNC-13S. We propose that in
these models can only be distinguished by biochemical mutants lacking either GOA-1 or serotonin, DAG levels
experiments. at the acetylcholine release sites increase thereby re-
Why doesn't the distribution of UNC-13S change in cruiting UNC-13S to neuromuscular junctions (Figure
dgk-1 DAG kinase mutants or in animals treated with 6). Once localized, UNC-13S could promote release of
phorbol esters? In both of these cases, acetylcholine acetylcholine, perhaps through its interactions with the
release is enhanced, yet UNC-13S::GFP remained dif- target SNARE syntaxin (Betz et al., 1997). Thus, both of
fusely distributed. The diffuse pattern of UNC-13S::GFP these results suggest that DAG directly regulates some
in these cases could reflect the fact that DAG levels are aspect of synaptic vesicle exocytosis or recycling. On
the other hand, our results do not exclude the possibilityelevated uniformly throughout the ventral cord axons,
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cDNA expression vector derived from PD49.78 (a gift of A. Fire),that other DAG-binding proteins (e.g., PKC) also contrib-
and nuIs41 contains an integrated version of the KP#207 transgene.ute to the behavioral effects of serotonin.
GOA-1 TransgenesSeveral published reports suggested that presynaptic
nuIs8 (a gift of A. Berger) contains an integrated wild-type GOA-1
DAG stimulates release of transmitter (Malenka et al., transgene. syIs17 (a gift of J. Mendel) contains an integrated heat
1986; Shapira et al., 1987; Segal, 1989; Stevens and shock±promoted GTPase-defective GOA-1(Q205L) transgene (Men-
del et al., 1995).Sullivan, 1998). Similarly, we showed that exogenous
UNC-13 Transgenesphorbol esters stimulate acetylcholine release in C. ele-
KP#268 encodes a full-length unc-13S::gfp fusion gene, which re-gans. Here, we show that an inhibitory neuromodulator
stored normal locomotion to animals carrying two different unc-13also relies on DAG as a second messenger; however,
alleles (e51 and e450). It contains a genomic fragment encom-
in this case, by reducing presynaptic DAG. Thus, we passing residues 1074±18913 of the ZC524 cosmid sequence (ac-
speculate that parallel pathways for production and con- cession Z73912); GFP was fused in frame at the carboxy terminus.
nuIs46 contains an integrated version of the KP#268 transgene.sumption of DAG at synaptic release sites could provide
KP#291 is identical to KP#268, except GFP is replaced by YFPa simple, elegant mechanism for positive and negative
(Rongo et al., 1998). KP#273 is also identical to KP#268, except itmodulation of synaptic transmission (Figure 6).
contains a point mutation resulting in the amino acid change H173K.Interestingly, all of the components in the serotonin
acr-2 Transgenes
pathway are conserved in mammalsÐincluding CAT-1 Expression of trangenes in ventral cord motor neurons was accom-
(VMAT2), GOA-1 (Gao), DGK-1 (DGKu), and UNC-13 plished with the acr-2 promoter (a gift of Y. Jin), which is expressed
in VA, DA, VB, DB, DA, IL1, RMD, and PVQ neurons (Y. Jin, personal(munc13±1). Therefore, it is possible that this DAG-sens-
communication). KP#305 contains the mature S1 subunit of PTX (aing mechanism represents a conserved signaling cas-
gift of T. Wilkie) in an acr-2 expression vector, KP#338 contains asette for modulation of synaptic transmission. In particu-
gfp-dgk-1a minigene containing the DGK-1a cDNA and the firstlar, given that the DAG kinases constitute a family of at
intron of DGK-1 fused to GFP at the N terminus in the acr-2 vector,
least 12 genes in mammals (Topham and Prescott, KP#284 contains a goa-1 Gao(Q205L) cDNA in the acr-2 vector, and
1999), we speculate that the different DAG kinase iso- KP#282 contains a SNB-1::CFP fusion (a gift of C. Rongo) in the
acr-2 vector. The pattern of cells expressing GFP in animals carryingforms are utilized to couple different inhibitory neuro-
the acr-2::gfp-dgk-1 construct was the same as that described formodulators to synaptic transmission. If this were the
the acr-2 promoter.case, DAG kinases might represent ideal targets for
drugs to manipulate the effects of different neuromodu-
Analysis of Behaviors and Drug Sensitivitieslators.
Drugs were purchased from Research Biochemicals or Sigma. Loco-
motion and egg laying assays were performed as described (Trent
et al., 1983; SeÂ galat et al., 1995), except we measured eggs laid inExperimental Procedures
liquid medium (M9 salts) over 2 hr. Drug treatments were as follows
(in mg/ml): for locomotion, 3.8 serotonin creatine sulfate, 0.125 fluox-Isolation of cat-1 and dgk-1 Mutations
etine; for egg laying, 3.8 serotonin creatine sulfate, 0.25 fluoxetine.The cat-1 allele nu90 and three dgk-1 alleles (nu199, nu76, and nu62)
Behaviors were assayed 2 hr after exposure to drugs. For locomo-were isolated as hyperactive mutants following mutagenesis with
tion rates, each animal was assayed three times for 1 min each. Atethylmethane sulfonate. cat-1(e1111) was isolated previously in a
least ten animals were tested in all cases. For animals expressingscreen for mutations that reduce the abundance of endogenous
GOA-1(Q205L) (syIs17), behaviors were analyzed 1 hr after a 30 mindopamine (Sulston et al., 1975). The nu90 allele is a missense muta-
heat shock at 338C.tion in the cat-1 VMAT (A406V). Two dgk-1 alleles were provided by
Sensitivity to aldicarb and levamisole was determined by analyz-M. Finney (n892) and E. Sawin (n2949). All of these alleles have a
ing the onset of paralysis following treatment with either 1 mMpurely recessive pattern of heredity. Allelism was determined by
aldicarb (Chem Services) or 100 mM levamisole (Sigma). Locomotioncomplementation tests and by meiotic mapping.
was assessed by prodding animals with a platinum wire every 10
min following exposure to drug. Where indicated, animals were pre-
Positional Cloning of dgk-1 treated (for 2 hr) prior to aldicarb treatment together with a second
We mapped the dgk-1 gene to a small region on the left arm of the drug, as follows: with 3.8 mg/ml serotonin creatine sulfate; with 2
X chromosome between aex-3 and unc-1. A cosmid clone (C06G11) mg/ml Phorbol 12-myristate 13-acetate (PMA); with 1 mg/ml ketan-
from this region corrected the locomotion and egg laying defects serin or 50 mg/ml methiothepin or 1 mg/ml haloperidol; with transient
of dgk-1 mutants in transgenic animals (data not shown). Sequence expression of GOA-1(Q205L) or DGK-1a from heat shock expression
changes in mutant alleles were determined by amplifying exons and vectors for 30 min at 338C. For each experiment, 25 animals were
exon/intron boundaries from mutant strains and direct sequencing tested blind with respect to the genotype or drug treatment. Each
of the amplified products by cycle sequencing. experiment was repeated at least three times.
Diacylglycerol Kinase AssaysTransgenes and Germline Transformation
HEK 293 cells were transfected with 1 mg of either GW1, KP#137,Plasmids were constructed by standard techniques, and sequences
KP#143, or FLAG DGKz (a gift of S. Prescott) using lipofectaminewere verified where appropriate; full details are available on request.
(GIBCO). DAG kinase activity in 7.5 mg of cell extract was assayedTransgenic strains were isolated by microinjecting various plasmids
48 hr after transfection, essentially as described (Tolias et al., 1998).(typically at either 50 or 100 ng/ml) using ttx-3::gfp (a gift of O. Hobert)
Phosphorylated lipids were quantified by scintillation counting.as a marker. Plasmids and transgenic strains were constructed as
follows.
DGK-1 Constructs Fluorescence Microscopy
GFP containing strains were mounted on agarose pads and viewedKP#174, a rescuing full-length gfp::dgk-1 fusion gene, contains GFP
fused in-frame at the amino terminus. nuIs45 contains an integrated on an Aviovert microscopes, using a Planapo 633 (NA 5 1.4), Plan-
neo 403 (NA 5 1.3) (Figure 4B), or Planneo 103 (NA 5 0.3) (Figure 4A)version of the KP#174 transgene. KP#329, a dgk-1::gfp fusion con-
struct, contains GFP fused in-frame at a unique XhoI site in exon objective. Images were captured with a Hamamatsu ORCA digital
camera. Digital images were processed to remove out of focus8 of dgk-1. nuIs15 contains an integrated version of the KP#329
transgene. KP#137 and KP#143 are full-length (2.85 kb) DGK-1a light and to give maximum intensity projections of a z series, using
Metamorph 4.0 image processing software (Universal Imaging Cor-and DGK-1b cDNA clones in the cytomegalovirus expression vector
GW1 (Choi et al., 1991). KP#207 is a heat shock±promoted DGK-1a poration). UNC-13 puncta were thresholded using Metamorph and
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counted by eye. UNC-13S::GFP and UNC-13S(H173K)::GFP in goa-1 pleckstrin homology domain with an overlapping Ras-associating
domain. J. Biol. Chem. 272, 10422±10428.mutants were quantified together blind to the identity of the
transgene. Houssa, B., de Widt, J., Kranenburg, O., Moolenaar, W.H., and van
Blitterswijk, W.J. (1999). Diacylglycerol kinase theta binds to and is
Acknowledgments negatively regulated by active RhoA. J. Biol. Chem. 274, 6820±6822.
Kazanietz, M.G., Lewin, N.E., Bruns, J.D., and Blumberg, P.M. (1995).
We thank the following for advice, strains, and reagents: M. Finney, Characterization of the cysteine-rich region of the Caenorhabditis
B. Sawin, D. Elkes, A. Coulson, Y. Kohara, J. Mendel, A. Fire, the elegans protein Unc-13 as a high affinity phorbol ester receptor.
C. elegans Genetic Stock Center, C. Carpenter, S. Prescott, H. Analysis of ligand-binding interactions, lipid cofactor requirements,
Bourne, A. Dittman, Y. Jin, T. Wilkie, and A. Berger. Fluoxetine was and inhibitor sensitivity. J. Biol. Chem. 270, 10777±10783.
a gift from Eli Lilly. We thank members of the lab, K. Zito, and A.
Koelle, M., and Horvitz, H.R. (1996). EGL-10 regulates G proteinDiAntonio for comments on the manuscript. We also thank T. Nia-
signaling in the C. elegans nervous system and shares a conservedcaris and L. Avery for communicating unpublished results. This work
domain with many mammalian proteins. Cell 84, 115±125.was supported by grants from the NIH, Millenium Pharmaceuticals,
Lochrie, M., Mendel, J., Sternberg, P., and Simon, M. (1991). Homol-and the Pew Foundation (J. M. K.), the Human Frontiers Science
ogous and unique G protein a subunits in the nematode C. elegans.Program (S. N.), and an EMBO long-term fellowship (L. S.).
Cell Regulation 2, 135±154.
Maes, M., and Meltzer, H. (1994). The serotonin hypothesis of majorReceived May 5, 1999; revised July 9, 1999.
depression. In Psychopharmacology: the Fourth Generation of
Progress, F. Bloom and D. Kupfer, eds. (New York: Raven Press),References
pp. 813±822.
Malenka, R.C., Madison, D.V., and Nicoll, R.A. (1986). PotentiationAhmed, S., Maruyama, I.N., Kozma, R., Lee, J., Brenner, S., and Lim,
L. (1992). The Caenorhabditis elegans unc-13 gene product is a of synaptic transmission in the hippocampus by phorbol esters.
Nature 321, 175±177.phospholipid-dependent high-affinity phorbol ester receptor. Bio-
chem. J. 287, 995±999. Maruyama, I.N., and Brenner, S. (1991). A phorbol ester/diacylglyc-
erol-binding protein encoded by the unc-13 gene of CaenorhabditisAlbertson, D.G., and Thomson, J.N. (1976). The pharynx of Caeno-
rhabditis elegans. Philos. Trans. R. Soc. 275, 299±325. elegans. Proc. Natl. Acad. Sci. USA 88, 5729±5733.
McDearmid, J.R., Scrymgeour-Wedderburn, J.F., and Sillar, K.T.Avery, L., and Horvitz, H.R. (1990). Effects of starvation and neuroac-
tive drugs on feeding in Caenorhabditis elegans. J. Exp. Zool. 253, (1997). Aminergic modulation of glycine release in a spinal network
controlling swimming in Xenopus laevis. J. Physiol. (Lond.) 503,263±270.
111±117.Berman, M.E., Tracy, J.I., and Coccaro, E.F. (1997). The serotonin
hypothesis of aggression revisited. Clin. Psychol. Rev. 17, 651±665. Mendel, J., Korswagen, H., Liu, K., Hadju-Cronin, Y., Simon, M.,
Plasterk, R., and Sternberg, P. (1995). Participation of the proteinBetz, A., Okamoto, M., Benseler, F., and Brose, N. (1997). Direct
Go in multiple aspects of behavior in C. elegans. Science 267, 1652±interaction of the rat unc-13 homologue Munc13±1 with the N termi-
1655.nus of syntaxin. J. Biol. Chem. 272, 2520±2526.
Miller, K., Alfonso, A., Nguyen, M., Crowell, J., Johnson, C., andBetz, A., Ashery, U., Rickmann, M., Augustin, I., Neher, E., Sudhof,
Rand, J. (1996). A genetic selection for Caenorhabditis elegans syn-T.C., Rettig, J., and Brose, N. (1998). Munc13±1 is a presynaptic
aptic transmission mutants. Proc. Natl. Acad. Sci. USA 93, 12593±phorbol ester receptor that enhances neurotransmitter release. Neu-
12598.ron 21, 123±136.
Nguyen, M., Alfonso, A., Johnson, C., and Rand, J. (1995). Caeno-Brundage, L., Avery, L., Katz, A., Kim, U.-J., Mendel, J.E., Sternberg,
rhabditis elegans mutants resistant to inhibitors of acetylcholines-P.W., and Simon, M.I. (1996). Mutations in a C. elegans Gqa gene
terase. Genetics 140, 527±535.disrupt movement, egg laying, and viability. Neuron 16, 999±1009.
Nonet, M., Grundahl, K., Meyer, B., and Rand, J. (1993). SynapticByrne, J.H., and Kandel, E.R. (1996). Presynaptic facilitation revis-
function is impaired but not eliminated in C. elegans mutants lackingited: state and time dependence. J. Neurosci. 16, 425±435.
synaptotagmin. Cell 73, 1291±1305.Choi, K., Aldrich, R., and Yellen, G. (1991). Tetraethylammonium
Oancea, E., and Meyer, T. (1998). Protein kinase C as a molecularblockade distinguishes two inactivation mechanisms in voltage-
machine for decoding calcium and diacylglycerol signals. Cell 95,activated K1 channels. Proc. Natl. Acad. Sci. USA 88, 5092±5095.
307±318.Crabbe, J., Phillips, T., Feller, D., Hen, R., Wenger, C., Lessov, C.,
Rand, J., and Nonet, M. (1997). Neurotransmitter assignments forand Schafer, G. (1996). Elevated alcohol consumption in null mutant
specific neurons. In C. elegans II, D. Riddle, T. Blumenthal, B. Meyer,mice lacking 5-HT1B serotonin receptors. Nat. Genet. 14, 98±101.
and J. Priess, eds. (Plainview, NY: Cold Spring Harbor Press), pp.de Bono, M., and Bargmann, C.I. (1998). Natural variation in a neuro-
1049±1052.peptide Y receptor homolog modifies social behavior and food re-
Rongo, C., Whitfield, C.W., Rodal, A., Kim, S.K., and Kaplan, J.M.sponse in C. elegans. Cell 94, 679±689.
(1998). LIN-10 is a shared component of the polarized protein local-Desai, C., Garriga, G., McIntire, S.L., and Horvitz, H.R. (1988). A
ization pathways in neurons and epithelia. Cell 94, 751±759.genetic pathway for the development of the Caenorhabditis elegans
Saudou, F., Amara, D.A., Dierich, A., LeMeur, M., Ramboz, S., Segu,HSN motor neurons. Nature 336, 638±646.
L., Buhot, M.C., and Hen, R. (1994). Enhanced aggressive behaviorDuerr, J.S., Frisby, D.L., Gaskin, J., Duke, A., Asermely, K., Huddle-
in mice lacking 5-HT1B receptor. Science 265, 1875±1878.ston, D., Eiden, L.E., and Rand, J.B. (1999). The cat-1 gene of Caeno-
Sawin, E. (1996). Genetic and cellular analysis of modulated behav-rhabditis elegans encodes a vesicular monoamine transporter re-
iors in C. elegans. PhD thesis, Massachusetts Institute of Technol-quired for specific monoamine-dependent behaviors. J. Neurosci.
ogy, Cambridge, Massachusetts.19, 72±84.
Schafer, W., and Kenyon, C. (1995). A calcium-channel homologueEdwards, D.H., and Kravitz, E.A. (1997). Serotonin, social status and
required for adaptation to dopamine and serotonin in C. elegans.aggression. Curr. Opin. Neurobiol. 7, 812±819.
Nature 375, 73±78.Horvitz, H.R., Chalfie, M., Trent, C., Sulston, J., and Evans, P. (1982).
Segal, M. (1989). Synaptic transmission between cultured rat hippo-Serotonin and octopamine in the nematode C. elegans. Science
campal neurons is enhanced by activation of protein kinase-C. Neu-216, 1012±1014.
rosci. Lett. 101, 169±174.Houssa, B., Schaap, D., van der Wal, J., Goto, K., Kondo, H., Yama-
SeÂ galat, L., Elkes, D., and Kaplan, J. (1995). Go modulation of seroto-kawa, A., Shibata, M., Takenawa, T., and van Blitterswijk, W. (1997).
nin-controlled behaviors in C. elegans. Science 267, 1648±1651.Cloning of a novel human diacylglycerol kinase (DGKtheta) con-
taining three cysteine-rich domains, a proline-rich region, and a Shapira, R., Silberberg, S.D., Ginsburg, S., and Rahamimoff, R.
Neuron
242
(1987). Activation of protein kinase C augments evoked transmitter
release. Nature 325, 58±60.
Singer, J.H., Bellingham, M.C., and Berger, A.J. (1996). Presynaptic
inhibition of glutamatergic synaptic transmission to rat motoneurons
by serotonin. J. Neurophysiol. 76, 799±807.
Soubrie, P. (1988). Serotonin and behavior, with special regard to
animal models of anxiety, depression, and waiting ability. In Neu-
ronal Serotonin, N. Osborne and M. Hamon, eds. (New York: Wiley).
Stevens, C.F., and Sullivan, J.M. (1998). Regulation of the readily
releasable vesicle pool by protein kinase C. Neuron 21, 885±893.
Sulston, J., Dew, M., and Brenner, S. (1975). Dopaminergic neurons
in the nematode Caenorhabditis elegans. J. Comp. Neurol. 163,
215±226.
Tecott, L., Sun, L., Akana, S., Strack, A., Lowenstein, D., Dallman,
M., and Julius, D. (1995). Eating disorder and epilepsy in mice lacking
5-HT2c serotonin receptors. Nature 374, 542±545.
Tolias, K., Couvillon, A., Cantley, L., and Carpenter, C. (1998). Char-
acterization of a Rac1- and RhoGDI-associated lipid kinase signaling
complex. Mol. Cell. Biol. 18, 762±770.
Topham, M.K., and Prescott, S.M. (1999). Mammalian diacylglycerol
kinases, a family of lipid kinases with signaling functions. J. Biol.
Chem. 274, 11447±11450.
Trent, C., Tsung, N., and Horvitz, H.R. (1983). Egg-laying defective
mutants of the nematode Caenorhabditis elegans. Genetics 104,
619±647.
Waggoner, L.E., Zhou, G.T., Schafer, R.W., and Schafer, W.R. (1998).
Control of alternative behavioral states by serotonin in Caenorhab-
ditis elegans. Neuron 21, 203±214.
Wang, C., and Zucker, R.S. (1998). Regulation of synaptic vesicle
recycling by calcium and serotonin. Neuron 21, 155±167.
Weinshenker, D., Garriga, G., and Thomas, J. (1995). Genetic and
pharmacological analysis of neurotransmitters controlling egg lay-
ing in C. elegans. J. Neurosci. 15, 6975±6985.
White, J.G., Southgate, E., Thomson, J.N., and Brenner, S. (1986).
The structure of the nervous system of Caenorhabditis elegans.
Philos. Trans. R. Soc. Lond. 314, 1±340.
Note Added in Proof
While our work was in review, Sternberg and colleagues published
a paper describing a genetic locus, sag-1, which is required for
GOA-1-mediated regulation of locomotion: Hadju-Cronin, Y.M.,
Chen, W.J., Patikoglou, G., Koelle, M.R., and Sternberg, P.W. (1999).
Antagonism between Goa and Gqa in Caenorhabditis elegans: the
RGS protein EAT-16 is necessary for Goa signaling and regulates
Gqa activity. Genes Dev. 13, 1780±1793. In collaboration with the
Sternberg lab, we have shown that sag-1 and dgk-1 are the same
gene.
